224 related articles for article (PubMed ID: 25595408)
1. Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy.
Kim GS; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
J Vasc Surg; 2015 May; 61(5):1223-30. PubMed ID: 25595408
[TBL] [Abstract][Full Text] [Related]
2. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
3. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
[TBL] [Abstract][Full Text] [Related]
4. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.
Wacker-Gußmann A; Bühren K; Schultheiss C; Braun SL; Page S; Saugel B; Schmid S; Mair S; Schoemig A; Schmid RM; Huber W
AJR Am J Roentgenol; 2014 Feb; 202(2):452-8. PubMed ID: 24450691
[TBL] [Abstract][Full Text] [Related]
5. Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization.
Ishibashi Y; Yamauchi M; Musha H; Mikami T; Kawasaki K; Miyake F
Angiology; 2010 Nov; 61(8):724-30. PubMed ID: 20947866
[TBL] [Abstract][Full Text] [Related]
6. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
[TBL] [Abstract][Full Text] [Related]
7. A head-to-head comparison of homocysteine and cystatin C as pre-procedure predictors for contrast-induced nephropathy in patients undergoing coronary computed tomography angiography.
Li S; Tang X; Peng L; Luo Y; Zhao Y; Chen L; Dong R; Zhu J; Chen Y; Liu J
Clin Chim Acta; 2015 Apr; 444():86-91. PubMed ID: 25687162
[TBL] [Abstract][Full Text] [Related]
8. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
[TBL] [Abstract][Full Text] [Related]
9. Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography.
Xu Q; Wang NN; Duan SB; Liu N; Lei R; Cheng W; Zhou SK
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27897324
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
[TBL] [Abstract][Full Text] [Related]
11. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
[TBL] [Abstract][Full Text] [Related]
12. Serum NGAL, cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children.
Benzer M; Alpay H; Baykan Ö; Erdem A; Demir IH
Ren Fail; 2016; 38(1):27-34. PubMed ID: 26584598
[TBL] [Abstract][Full Text] [Related]
13. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C and contrast-induced acute kidney injury.
Briguori C; Visconti G; Rivera NV; Focaccio A; Golia B; Giannone R; Castaldo D; De Micco F; Ricciardelli B; Colombo A
Circulation; 2010 May; 121(19):2117-22. PubMed ID: 20439784
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization.
Shukla AN; Juneja M; Patel H; Shah KH; Konat A; Thakkar BM; Madan T; Prajapati J
Indian Heart J; 2017; 69(3):311-315. PubMed ID: 28648419
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline for the prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty: a randomized controlled trial.
Aslanabadi N; Afsar Gharebagh R; Moharramzadeh S; Entezari-Maleki T
Int Urol Nephrol; 2019 Apr; 51(4):699-705. PubMed ID: 30830654
[TBL] [Abstract][Full Text] [Related]
19. Role of serum cystatin C in the prediction of contrast-induced nephropathy after intra-arterial interventions.
Wang ZY; Wang YL; Wei J; Jin L; Wang ZC
Chin Med J (Engl); 2020 Feb; 133(4):408-414. PubMed ID: 31977562
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Serum Cystatin C and Creatinine Level Changes for Prognosis of Patients After Peripheral Arterial Angiography.
Yang Y; Zhao X; Tang X; Lu J; Zhou M; Wang W; Wang L; Guo D; Ding F
Angiology; 2015 Sep; 66(8):766-73. PubMed ID: 25344529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
